Clinical Trial Update: Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses [Phase 1]

View source ↗

Summary

This completed Phase 1 pharmacokinetic study in healthy volunteers evaluated exposure of the inhaled components Fluticasone Furoate, Vilanterol, and Umeclidiniu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)
• Umeclidinium (umeclidinium)
• Vilanterol (vilanterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED